The effect of duloxetine on penicillin-induced epileptiform activity in rats

References

• Dichter MA. Emerging insights into mechanisms of epilepsy: implications for new antiepileptic drug development. Epilepsia. 1994;35(Suppl 4):51–57.
   Web of Science ®Google Scholar
• Gilliam F, Kanner AM. Treatment of depressive disorders in epilepsy patients. Epilepsy Behav. 2002;3:2–9.
   PubMed Web of Science ®Google Scholar
• Lambert MV, Robertson MM. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia. 1999;40:21–47.
   PubMed Web of Science ®Google Scholar
• Kanner AM. Can neurobiological pathogenic mechanisms of depression facilitate the development of seizure disorders? Lancet Neurol. 2012;11:1093–1102.
   PubMed Web of Science ®Google Scholar
• Sankar R, Mazarati A. Neurobiology of depression as a comorbidity of epilepsy. In: Noebels JL, Avoli M, Rogawski MA, et al. editors. Jasper’s basic mechanisms of the epilepsies [Internet]. 4th ed. Bethesda (MD): National Center for Biotechnology Information (US); 2012:1399–1416.
   Google Scholar
• Jones JE, Hermann BP, Barry JJ, et al. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav. 2003;4:31–38.
   PubMed Web of Science ®Google Scholar
• Hesdorffer DC, Ishihara L, Mynepalli L, et al. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol. 2012;72:184–191.
   PubMed Web of Science ®Google Scholar
• Zienowicz M, Wisłowska A, Lehner M, et al. The effect of fluoxetine in a model of chemically induced seizures—behavioral and immunocytochemical study. Neurosci Lett. 2005;373(3):226–231.
   PubMed Web of Science ®Google Scholar
• Payandemehr B, Bahremand A, Rahimian R, et al. 5-HT(3) receptor mediates the dose-dependent effects of citalopram on pentylenetetrazole-induced clonic seizure in mice: involvement of nitric oxide. Epilepsy Res. 2012;101:217–227.
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Gołyska D, Luszczki JJ, et al. Effect of acutely and chronically administered venlafaxine on the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock model. Eur J Pharmacol. 2011;670(1):114–120.
   PubMed Web of Science ®Google Scholar
• Ahern TH, Javors MA, Eagles DA, et al. The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice. Neuropsychopharmacol. 2006;31:730–738.
   PubMed Web of Science ®Google Scholar
• Santos JG Jr., Do Monte FH, Russi M, et al. Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats. Braz J Med Biol Res. 2002;35(4):469–472.
   PubMed Web of Science ®Google Scholar
• Popławska M, Wroblewska D, Borowicz KK, et al. Interactions between an antidepressant reboxetine and four classic antiepileptic drugs in the mouse model of myoclonic seizures. Pharmacol Rep. 2015;67(6):1141–1146.
   PubMed Web of Science ®Google Scholar
• Kumar U, Medel-Matus JS, Redwine HM, et al. Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy. Epilepsia. 2016;57(3):506–515.
   PubMed Web of Science ®Google Scholar
• Wong DT, Bymaster FP, Mayle DA, et al. LY248686, a new inhibitor of serotonin and norepinephrine uptake. Neuropsychopharmacol. 1993;8(1):23–33.
   PubMed Web of Science ®Google Scholar
• Menchetti M, Gozzi BF, Saracino MA, et al. Non-fatal overdose of duloxetine in combination with other antidepressants and benzodiazepines. World J Biol Psychiatry. 2009;10:385–389.
   PubMed Web of Science ®Google Scholar
• Santana-Coelho D, Souza-Monteiro JR, Paraense RS, et al. Antidepressant drugs in convulsive seizures: pre-clinical evaluation of duloxetine in mice. Neurochem Int. 2016;99:62–71.
   PubMed Web of Science ®Google Scholar
• Citraro R, Leo A, De Fazio P, et al. Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive‐like behavior in the WAG/Rij rat model of absence epilepsy. Br J Pharmacol. 2015;172(12):3177–3188.
   PubMed Web of Science ®Google Scholar
• Akdogan I, Yonguc NG. Experimental epilepsy models and morphologic alterations of experimental epilepsy models in brain and hippocampus. In: Kaneez FS, editor. Underlying mechanisms of epilepsy. Croatia: InTech; 2011. p. 269–282.
   Google Scholar
• Kozan R, Ayyildiz M, Agar E. The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats. Epilepsia. 2009;50(7):1760–1767.
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sydney: Academic Press; 1986.
   Google Scholar
• Ayyildiz M, Coskun S, Yildirim M, et al. The effects of ascorbic acid on penicillin-induced epileptiform activity in rats. Epilepsia. 2007;48(7):1388–1395.
   PubMed Web of Science ®Google Scholar
• Gilliam FG, Barry JJ, Hermann BP, et al. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol. 2006;5(5):399–405.
   PubMed Web of Science ®Google Scholar
• Fernandez-Guardiola A, Martinez A, Fernandez-Mas R. Repeated penicillin-induced amygdala epileptic focus in freely moving cats. EEG, polysomnographic (23 h recording), and brain mapping study. Epilepsy Res. 1995;22:127–136.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Trujano ME, Tapia E, Lopez-Meraz L, et al. Anticonvulsant effect of Annona diversifolia Saff. And palmitone on penicillin-induced convulsive activity. A behavioral and EEG study in rats. Epilepsia. 2006;47:1810–1817.
   PubMed Web of Science ®Google Scholar
• Collins RC. Kindling of neuroanatomic pathways during recurrent focal penicillin seizures. Brain Res. 1978;150:503–517.
   PubMed Web of Science ®Google Scholar
• Pellicciari A, Balzarro B, Scaramelli A, et al. Generalized tonic-clonic seizure secondary to duloxetine poisoning: A short report with favorable out come. Neurotoxicology. 2012;33(2):189–190.
   PubMed Web of Science ®Google Scholar
• Melani F, Rosati E, Chiocchetti B, et al. Antidepressant-associated myoclonic status in a patient with symptomatic generalized epilepsy: does risk occur with therapeutic doses? Epilepsy Behav. 2009;14(4):681–683.
   PubMed Web of Science ®Google Scholar
• Cardamone L, Salzberg MR, O’brien TJ, et al. Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder? Br J Pharmacol. 2013;168(7):1531–1554.
   PubMed Web of Science ®Google Scholar
• Mazarati A, Siddarth P, Baldwin RA, et al. Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. Brain. 2008;131:2071–2083.
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Ikeda Y, Sakai A, et al. Reversal of hippocampal neuronal maturation by serotonergic antidepressants. Proc Natl Acad Sci. 2010;107:8434–8439.
   PubMed Web of Science ®Google Scholar
• Karpova NN, Pickenhagen A, Lindholm J, et al. Fear erasure in mice requires synergy between antidepressant drugs and extinction training. Science. 2011;334:1731–1734.
   PubMed Web of Science ®Google Scholar
• Lee HM, Chai OH, Hahn SJ, et al. Antidepressant drug paroxetine blocks the open pore of Kv3. 1 potassium channel. Korean J Physiol Pharmacol. 2018;22(1):71–80.
   PubMed Web of Science ®Google Scholar
• Cardamone L, Salzberg MR, Koe AS, et al. Chronic antidepressant treatment accelerates kindling epileptogenesis in rats. Neurobiol Dis. 2014;63:194–200.
   PubMed Web of Science ®Google Scholar
• Rudy B, Chow A, Lau D, et al. Contributions of Kv3 channels to neuronal excitability. Ann N Y Acad Sci. 1999;868:304–343.
   PubMed Web of Science ®Google Scholar
• Ozaita A, Martone ME, Ellisman MH, et al. Differential subcellular localization of the two alternatively spliced isoforms of the Kv3.1 potassium channel subunit in brain. J Neurophysiol. 2002;88:394–408.
   PubMed Web of Science ®Google Scholar
• Stahl SM. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord. 1998;51:215–235.
   PubMed Web of Science ®Google Scholar
• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112–1120.
   PubMed Web of Science ®Google Scholar
• Wada Y, Shiraishi J, Nakamura M, et al. Effects of the 5-HT3 receptor agonist 1-(m-chlorophenyl)- biguanide in the rat kindling model of epilepsy. Brain Res. 1997a;759:313–316.
   PubMed Web of Science ®Google Scholar
• Wada Y, Shiraishi J, Nakamura M, et al. Role of serotonin receptor subtypes in the development of amygdaloid kindling in rats. Brain Res. 1997b;747:338–342.
   PubMed Web of Science ®Google Scholar
• Weinshenker D, Szot P. The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. Pharmacol Ther. 2002;94:213–233.
   PubMed Web of Science ®Google Scholar
• Giorgi FS, Pizzanelli C, Biagioni F, et al. The role of norepinephrine in epilepsy: from the bench to the bedside. Neurosci Biobehav Rev. 2004;28:507–524.
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Zarczuk R, Latalski M, et al. Reboxetine and its influence on the action of classical antiepileptic drugs in the mouse maximal electroshock model. Pharmacol Rep. 2014;66(3):430–435.
   PubMed Web of Science ®Google Scholar
• Kanner AM. Epilepsy, suicidal behaviour, and depression: do they share common pathogenic mechanisms? Lancet Neurol. 2006b;5:107–108.
   PubMed Web of Science ®Google Scholar